| Dr Alan Quoc Doan, PHARMD | |
|
400 N Pepper Ave, Colton, CA 92324-1819 | |
| (909) 580-0016 | |
| Not Available |
| Full Name | Dr Alan Quoc Doan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073735262 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 54112 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Quoc Doan, PHARMD 400 N Pepper Ave, Colton, CA 92324-1819 Ph: (909) 580-0016 | Dr Alan Quoc Doan, PHARMD 400 N Pepper Ave, Colton, CA 92324-1819 Ph: (909) 580-0016 |
News Archive
Patients with acute physical rehabilitation needs now can undergo inpatient treatment close to home thanks to a new partnership between Adventist Hinsdale Hospital and Marianjoy Rehabilitation Hospital. Announced today, the cooperative effort unites two organizations with similar holistic approaches to rehabilitative patient care for a variety of conditions in multiple settings.
Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011. Thousands of residents were affected. A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December 2010, by Premier of Queensland, Anna Bligh. DSM recognizes the efforts of Queenslanders who pitched in to help their fellow citizens clean-up in the wake of the floods and help families in need, many of whom lost everything.
Feintuch Communications, Inc. (www.feintuchcommunications.com) has created an integrated public and investor relations healthcare and life sciences practice, naming Jules Abraham as vice president of the firm and managing director of the new group.
Incyte Corporation announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase III trial for its JAK1 and JAK2 inhibitor, INCB18424 in patients with polycythemia vera (PV), a blood cancer that belongs to a group of diseases known as myeloproliferative neoplasms (MPNs).
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
› Verified 4 days ago
Dr. Lia Pop, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-1027 Fax: 909-580-1033 | |
Mr. Quang Van Ma, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-0016 | |
Jody Anne Marie Allanigue Gotoc, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 Northwestern Cir, Colton, CA 92324 Phone: 909-263-7437 | |
Yongmin Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1040 S Mount Vernon Ave, E, Colton, CA 92324 Phone: 909-222-4884 Fax: 909-222-4921 | |
Katherine Kim-ngan Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92704 Phone: 909-580-1000 | |
Alexander Chang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-1900 |